Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Genetic Technologies Announced Tuesday, It Established Precision Oncology Division, Announced geneType Precision Oncology Brand Portfolio Of New Diagnostic Tests

Author: Charles Gross | April 17, 2024 05:23am

4 Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, &ldquo, Company&rdquo, , &ldquo, GTG&rdquo, )), a global leader in genomicsbased tests in health, wellness and serious disease, is pleased to announce the Company has established a precision oncology division and announced its highly anticipated portfolio of new diagnostic tests under its geneType precision oncology brand.

Posted In: GENE


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist